# reload+after+2024-01-23 05:44:37.927996
address1§Dr. Neergaards Vej
address2§5th Floor
city§Horsholm
zip§2970
country§Denmark
phone§45 53 53 18 50
website§https://www.evaxion-biotech.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase 1/2a trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. Evaxion Biotech A/S was incorporated in 2008 and is based in Hørsholm, Denmark.
fullTimeEmployees§63
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Niels Iversen Moller M.D.', 'age': 44, 'title': 'Co-Founder, VP of Business & Director', 'yearBorn': 1979, 'fiscalYear': 2022, 'totalPay': 120000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Andreas Holm Mattsson', 'age': 47, 'title': 'Co-Founder and Chief AI & Culture Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 319000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jesper Nyegaard Nissen', 'age': 53, 'title': 'CFO & COO', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 346967, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Birgitte  Rono Ph.D.', 'age': 47, 'title': 'Chief Scientific Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 336000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christian  Kanstrup', 'age': 51, 'title': 'Chief Executive Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jürgen  Langhärig EMBA, Ph.D.', 'title': 'Head of Business Development & Member of Advisory Board', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.046
currency§USD
dateShortInterest§1702598400
forwardEps§-0.37
exchange§NCM
quoteType§EQUITY
shortName§Evaxion Biotech A/S
longName§Evaxion Biotech A/S
firstTradeDateEpochUtc§1612535400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§10e58503-7bd5-32f9-974e-d651a4f9f505
gmtOffSetMilliseconds§-18000000
targetHighPrice§5.0
targetLowPrice§2.0
targetMeanPrice§3.5
targetMedianPrice§3.5
recommendationMean§2.5
recommendationKey§buy
numberOfAnalystOpinions§2
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
